Syncromune founder Jason R Williams, MD Work is the Basis of This Study.

Reference: Ali Gorman, Brad Loncar, & Brian Orelli. (2024, April 9). Syncromune’s AACR late-breaker of phase 1 data for the sync-T immunotherapy drug-device combo in mCRPC. BiotechTV. https://www.biotechtv.com/post/syncromune-april-8-2024